We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Asymptomatic Individuals May Shed Infective Leptospira Bacteria in Their Urine

By LabMedica International staff writers
Posted on 09 Mar 2016
An international team of molecular microbiologists has assembled a comprehensive, cross-species genomic comparison of all 20 known species of Leptospira and determined that a pool of asymptomatic individuals was shedding the bacteria in their urine. More...


The more than 200 types of spiral-shaped bacteria (spirochetes) in the genus Leptospira are classified as pathogenic, intermediately pathogenic, or saprophytic based on their ability to cause disease and on genetic information.

In humans, approximately 90% of cases of the disease are mild leptospirosis. Others experience a severe form of the disease known as Weil's disease, which is characterized by liver damage (causing jaundice), kidney failure, and bleeding. Additionally, the heart and brain can be affected; meningitis of the outer layer of the brain, encephalitis of brain tissue with same signs and symptoms; and lung affected as the most serious and life-threatening of all leptospirosis complications. The infection is often incorrectly diagnosed due to the nonspecific symptoms.

An international team of molecular microbiologists sought evidence for human reservoirs of the bacteria and for genetic clues as to why it caused such a broad range of symptoms among infected individuals. The investigators from the United States, Australia, France, England, The Netherlands, Canada, Uruguay, Brazil, Peru, and Thailand used a combination of epidemiological data, serology, and molecular detection of the leptospiral 16S rRNA gene to identify asymptomatic urinary shedders of Leptospira among the inhabitants of a rural village in the Peruvian Amazon region.

They reported in the February 23, 2016, online edition of the journal PLOS Neglected Tropical Diseases that approximately one-third of 314 asymptomatic participants had circulating anti-leptospiral antibodies. Among enrolled participants, 189 (59%) had evidence of recent infection. Among these people, 13 (all women) had Leptospira DNA-positive urine samples. A group of 102 long-term asymptomatic individuals without serological evidence of recent infection was identified. Within this group, six (5.9%) excreted pathogenic and intermediate-pathogenic Leptospira in their urine.

The results showed that asymptomatic renal colonization of Leptospira bacteria in a region of high disease transmission was common, including among people without serological or clinical evidence of recent infection. Both pathogenic and intermediate Leptospira could persist as renal colonization in humans.

Leptospira is the most complex genus of bacteria that infects humans,” said senior author Dr. Joseph M. Vinetz, professor of medicine at the University of California, San Diego (USA). “This work compares the complete genome sequences of all known species of Leptospira to discover which genes make this bacterium a pathogen. It provides a roadmap for future research, including finding new ways to diagnose infection and vaccine development.”

“One fascinating finding was discovering the CRISPR-Cas genetic machinery only in pathogenic Leptospira, but not in the intermediate or non-infectious groups of the genus. The evolutionary acquisition of novel CRISPR elements, which are only in pathogenic Leptospira, probably hastened adaptation to human infection. The significance of this observation remains to be explored,” said Dr. Vinetz.

Related Links:

University of California, San Diego



Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
Portable Electronic Pipette
Mini 96
New
Laboratory Software
ArtelWare
New
Pipette
Accumax Smart Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The VENTANA HER2 (4B5) test is now CE-IVDR approved (Photo courtesy of Roche)

Companion Diagnostic Test Identifies HER2-Ultralow Breast Cancer and Biliary Tract Cancer Patients

Breast cancer is the most common cancer in Europe, with more than 564,000 new cases and 145,000 deaths annually. Metastatic breast cancer is rising in younger populations and remains the leading cause... Read more

Technology

view channel
Image: Conceptual design of the CORAL capsule for microbial sampling in the small intestine (H. Mohammed et al., Device (2025). DOI: 10.1016/j.device.2025.100904)

Coral-Inspired Capsule Samples Hidden Bacteria from Small Intestine

The gut microbiome has been linked to conditions ranging from immune disorders to mental health, yet conventional stool tests often fail to capture bacterial populations in the small intestine.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.